| LINC Deadline News: Lincoln Educational Investors are Notified of the Imminent November 10 Securities Fraud Class Action – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:34 |
| CC Deadline News: Chemours Investors are Notified of the Imminent December 7 Securities Fraud Class Action – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:33 |
| BBNX Deadline News: Beta Bionics Investors are Notified of the Imminent November 3 Securities Fraud Class Action – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:33 |
| GOOG, GOOGL Deadline News: Alphabet Investors are Notified of the Imminent December 1 Securities Fraud Class Action – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:32 |
| Tango Presents Promising Results from Phase 1/2 Study of Vopimetostat and Daraxonrasib in Pancreatic Cancer and Provides Updates to Development Strategy |
Globe Newswire |
10/23 |
06:30 |
| The stadium hosting Sunday's NFL game in Paris has seen much sporting drama but also a terror attack |
AP Online |
10/23 |
06:01 |
| How Spanish coaches became soccer's hottest commodity |
AP Online |
10/23 |
06:01 |
| Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3 |
Globe Newswire |
10/23 |
06:00 |
| Legacy Offer Releases Tacoma Home-Selling Guidance as Pierce County Listings Reach 55 Days on Market |
Globe Newswire |
10/23 |
06:00 |
| MISSION SUCCESS: Rocket Lab Launches 98th Electron Mission |
Globe Newswire |
10/23 |
04:47 |
| Correction: Norsk Hydro: Solid results and strong performance |
Globe Newswire |
10/23 |
04:21 |
| Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA |
Globe Newswire |
10/23 |
04:00 |
| Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer |
Globe Newswire |
10/23 |
04:00 |
| ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial |
Globe Newswire |
10/23 |
03:15 |
| ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026 |
Globe Newswire |
10/23 |
03:15 |
| Solidgate Secures MiCA Authorization as a Crypto-Asset Service Provider |
Globe Newswire |
10/23 |
03:00 |
| Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal cancer |
Globe Newswire |
10/23 |
02:30 |
| Sigma FP2 Mirrorless Camera Evolves the Compact, Hybrid, Full-Frame Formula, Announced; YouTube First Look Video and More Info at B&H |
Globe Newswire |
10/23 |
02:30 |
| Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01 |
Globe Newswire |
10/23 |
02:00 |
| Ipsos: Organic growth of 2.0% in Q3 |
Globe Newswire |
10/23 |
01:49 |
| Caleb Williams throws 2 TD passes as the Bears beat Drake Maye and the Patriots 30-24 |
AP Online |
10/23 |
01:39 |
| Umbrella Lab Announces Documentation and Traceability Update for BPC-157 Peptide |
Globe Newswire |
10/23 |
01:18 |
| Sodexo - Fiscal 2026 results: organic growth above guidance; Fiscal 2027 outlook confirmed |
Globe Newswire |
10/23 |
01:00 |
| Norsk Hydro: Solid results and strong performance |
Globe Newswire |
10/23 |
01:00 |
| Raymond scores twice in the Red Wings' 5-2 victory over the Canucks |
AP Online |
10/23 |
00:48 |
